| Application no. and date | 20195373.4 (espacenet) (Federated) (European Patent Register), 20181106 | | Patent/reg. no. and date | DK/EP 3785733, 20220105 | | Publication date | 20210303 | | Priority no. and date | US 201762582141 P, 20171106, EP 17200219, 20171106, US 201862663647 P, 20180427, EP 18169952, 20180427 | | EP pub. no. and date |
EP 3785733 20210303 | | Effective date | | | Applicant/owner | Stalicla S.A., Avenue de Sécheron 15
1202 Geneva, CH | | Applicant ref. no. | 165983/BT/CB | | Inventor | Durham, Lynn, STALICLA SA
Avenue de Sécheron 15
1202 Genève, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/196 (2006.01) , A61K 31/437 (2006.01) , A61K 45/00 (2006.01) , A61P 25/00 (2006.01) | | Title | FARMACEUTISK SAMMENSÆTNING TIL BEHANDLING AF AUTISME | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
